Literature DB >> 10958859

Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions.

L V Rao1, A O Okorodudu, J R Petersen, M T Elghetany.   

Abstract

Prothrombin time (PT) and activated partial thromboplastin time (aPTT) are common laboratory tests that are useful in the diagnosis of coagulation disorders and monitoring anticoagulant therapy. Recent expansions in the outreach laboratory services at our institution prompted us to investigate the shipping limitations for some tests, including PT and aPTT. Although we followed NCCLS guidelines for the collection of blood specimens, we observed falsely elevated PT and aPTT values due to the different storage conditions. The objective of this study is to determine the effect of conditions and duration of storage on PT and aPTT tests using plasma and whole blood samples, respectively. For this study, 36 plasma samples with normal and prolonged PT and aPTT were exposed to different storage conditions. Blood was centrifuged immediately and plasma was stored at room temperature (RT), refrigerated at 4 degrees C, or frozen at -20 degrees C. The samples were analyzed at 0 h and repeated at 6, 12 and 24 h under various conditions. Although statistically significant differences were observed for plasma samples for normal PT tests after 12 h at refrigerated and frozen storage conditions, the differences would not change the clinical interpretation of the results. On the other hand, samples stored refrigerated or at RT showed significant differences for aPTT at 24 h. These differences would change clinical interpretation, especially for samples with normal or near normal aPTT times. Interestingly, aPTT was significantly higher for samples stored frozen when compared to refrigerated and RT conditions at 6 h. Similar patterns were also observed on ten whole blood samples with normal PT and aPTT values. In conclusion, either plasma or whole blood samples can be accepted for PT testing up to 24 h and for aPTT testing up to 12 h only, when transported either at RT or at 4 degrees C.

Entities:  

Mesh:

Year:  2000        PMID: 10958859     DOI: 10.1016/s0009-8981(00)00288-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Effect of storage conditions on prothrombin time, activated partial thromboplastin time and fibrinogen concentration on canine plasma samples.

Authors:  Giuseppe Piccione; Stefania Casella; Claudia Giannetto; Elisabetta Giudice
Journal:  J Vet Sci       Date:  2010-06       Impact factor: 1.672

Review 2.  Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories.

Authors:  A Magnette; M Chatelain; B Chatelain; H Ten Cate; F Mullier
Journal:  Thromb J       Date:  2016-12-12

3.  In vivo assessment of anticoagulant and antiplatelet effects of Syzygium cumini leaves extract in rabbits.

Authors:  Ahad Abdul Rehman; Azra Riaz; Muhammad Arif Asghar; Muhammad Liaquat Raza; Shadab Ahmed; Kamran Khan
Journal:  BMC Complement Altern Med       Date:  2019-09-03       Impact factor: 3.659

4.  Assessment of Stability of Prothrombin Time, International Normalized Ratio, and Activated Partial Thromboplastin Time Under Different Storage Conditions in Human Plasma.

Authors:  Parag Patil; Tushar Sehgal; Priyanka Goswami; Malvika Gaur; Maroof Khan; Shivam Pandey; Sudip K Datta
Journal:  Cureus       Date:  2022-01-15

5.  Effects of storage time and temperature on coagulation tests and factors in fresh plasma.

Authors:  Limin Feng; Ying Zhao; Hongcan Zhao; Zhexin Shao
Journal:  Sci Rep       Date:  2014-01-27       Impact factor: 4.379

6.  In vitro assessment of quality of citrate-phosphate-dextrose-adenine-1 preserved feline blood collected by a commercial closed system.

Authors:  Chiara Crestani; Annalisa Stefani; Antonio Carminato; Angelica Cro; Katia Capello; Michela Corrò; Elisa Bozzato; Franco Mutinelli; Marta Vascellari
Journal:  J Vet Intern Med       Date:  2018-04-10       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.